U.S. Physical Therapy (NYSE:USPH) Announces Earnings Results

U.S. Physical Therapy (NYSE:USPH) released its quarterly earnings data on Wednesday. The company reported $0.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.81 by ($0.06), Zacks reports. U.S. Physical Therapy had a return on equity of 8.81% and a net margin of 4.36%.During the same period last year, the firm earned $0.81 EPS. The business’s quarterly revenue was up 8.5% on a year-over-year basis.

U.S. Physical Therapy Stock Performance

Shares of USPH traded up $1.47 during mid-day trading on Wednesday, hitting $77.33. 266,614 shares of the company’s stock were exchanged, compared to its average volume of 239,484. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.41. U.S. Physical Therapy has a fifty-two week low of $58.19 and a fifty-two week high of $93.50. The business’s 50 day moving average is $69.36 and its two-hundred day moving average is $74.34. The firm has a market capitalization of $1.18 billion, a P/E ratio of 29.18, a P/E/G ratio of 2.10 and a beta of 1.13.

Insider Transactions at U.S. Physical Therapy

In related news, Director Peter Francis Minan purchased 492 shares of the company’s stock in a transaction that occurred on Monday, June 8th. The shares were purchased at an average price of $63.14 per share, for a total transaction of $31,064.88. Following the transaction, the director directly owned 2,923 shares of the company’s stock, valued at approximately $184,558.22. The trade was a 20.24% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 2.40% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of USPH. Bank of America Corp DE increased its holdings in shares of U.S. Physical Therapy by 77.2% in the third quarter. Bank of America Corp DE now owns 317,200 shares of the company’s stock valued at $26,946,000 after purchasing an additional 138,194 shares during the period. Schroder Investment Management Group grew its position in U.S. Physical Therapy by 45.9% in the 4th quarter. Schroder Investment Management Group now owns 364,253 shares of the company’s stock valued at $29,603,000 after buying an additional 114,618 shares during the last quarter. 4D Advisors LLC purchased a new position in U.S. Physical Therapy in the 3rd quarter valued at $9,344,000. First Trust Advisors LP increased its stake in U.S. Physical Therapy by 607.2% in the 4th quarter. First Trust Advisors LP now owns 69,834 shares of the company’s stock valued at $5,453,000 after buying an additional 59,959 shares during the period. Finally, Two Sigma Investments LP increased its stake in U.S. Physical Therapy by 718.8% in the 3rd quarter. Two Sigma Investments LP now owns 60,267 shares of the company’s stock valued at $5,120,000 after buying an additional 52,907 shares during the period.

Analyst Ratings Changes

Several brokerages have recently weighed in on USPH. Citigroup reissued a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Friday, July 24th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Friday, May 29th. Barrington Research cut their target price on U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating on the stock in a research report on Wednesday, May 13th. Citizens Jmp reiterated a “market outperform” rating and set a $98.00 target price on shares of U.S. Physical Therapy in a research report on Wednesday, June 24th. Finally, Zacks Research raised U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a report on Wednesday, May 27th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $97.50.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.